Anaphylaxis Discharge Medications
All patients discharged after anaphylaxis must receive an epinephrine auto-injector prescription (2 doses) plus a 2-3 day course of oral antihistamines (H1 and H2 blockers) and corticosteroids. 1
Essential Discharge Prescriptions
First-Line (Mandatory)
- Epinephrine auto-injector: Prescribe 2 doses with instructions for self-administration 1
- This is the single most critical discharge medication to prevent mortality from recurrent or biphasic reactions
- Patients should be instructed to use immediately if symptoms recur
Adjunctive Medications (Recommended for 2-3 days)
H1 Antihistamine:
- Diphenhydramine every 6 hours for 2-3 days 1
- Alternative: Non-sedating second-generation antihistamine 1
H2 Antihistamine:
- Ranitidine twice daily for 2-3 days 1
- The combination of H1 + H2 antihistamines is superior to H1 alone 2
Corticosteroid:
- Prednisone daily for 2-3 days 1
- Rationale: May prevent biphasic or protracted anaphylaxis, though evidence is limited 2, 3
Clinical Reasoning
The discharge medication strategy addresses two critical concerns: (1) immediate treatment availability if symptoms recur and (2) potential prevention of biphasic reactions (which can occur 4-72 hours after initial episode). While epinephrine is the only proven life-saving intervention, the short course of antihistamines and corticosteroids is recommended by major guidelines despite low-certainty evidence for preventing biphasic reactions 3.
Important Caveats
Biphasic reactions occur in a minority of patients but are unpredictable based on initial presentation 2. The adjunctive medications provide theoretical protection during this vulnerable period.
Corticosteroids lack strong evidence for preventing biphasic anaphylaxis, but guidelines recommend them based on expert consensus and potential benefit with minimal harm 3. The 2020 GRADE analysis found no clear evidence supporting their role, yet they remain standard practice 3.
Auto-injector prescribing rates are concerningly low in real-world practice (only 9-14% in recent U.S. studies) 4, 5, representing a critical gap between guidelines and practice that directly impacts patient safety.
Additional Discharge Requirements
Beyond medications, ensure:
- Written anaphylaxis emergency action plan 1
- Education on allergen avoidance and symptom recognition 1
- Referral to allergist/immunologist 1
- Instructions to monitor auto-injector expiration dates (expires after 1 year) 1
The epinephrine auto-injector is non-negotiable—failure to prescribe it at discharge represents substandard care and leaves patients vulnerable to fatal outcomes from recurrent anaphylaxis.